WHO Technical Report Series, No. 981 - World Health Organization

WHO Expert Committee on Specifications for Pharmaceutical Preparations Forty-seventh report
International Pharmaceutical Excipients Council (IPEC)
Dr E. Krämer, Good distribution practices (GDP) Committee Chair, IPEC Europe, Brussels,
Belgium
International Pharmaceutical Federation (FIP)
Dr L. Besançon, The Hague, Netherlands
International Society for Pharmaceutical Engineering (ISPE)
Dr G.L. France, Region Head, Quality Europe, Novartis Consumer Health Services SA,
Novartis Group: Quality Systems & Standards, Switzerland
World Self-Medication Industry (WSMI)
Dr R. Torano, Quality Executive, Pharmacopoeial Intelligence and Advocacy, GlaxoSmithKline,
England
Observer
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Dr A. Hayes, Geneva, Switzerland
WHO Technical Report Series, No. 981, 2013
viii
Pharmacopoeias 6
British Pharmacopoeia Commission
Mrs M. Vallender, Editor-in-Chief, BP and Laboratory Services, London, England
Pharmacopoeia of the People's Republic of China
Dr P. Wang, Deputy Secretary-General, Beijing, People's Republic of China
Indonesian Pharmacopoeia Commission
Dr A. Zaini, Director for Standardization of Drug and Food Control, National Agency of
Therapeutic Products and Household Healthcare, Percetakan, Indonesia
Committee of the Japanese Pharmacopoeia
Dr T. Kawanishi, Deputy Director General, National Institute of Health Sciences, Tokyo,
Japan
Pharmacopoeia of the Republic of Korea
Dr I. Kim, Director, Pharmaceutical Standardization and Research Division, National Institute
of Food and Drug Safety Evaluation (NIFDS), Korea Food and Drug Administration
(KFDA), Chungbuk, Republic of Korea;
Dr H.-S. Kim, Deputy Director, Pharmaceutical Standardization Division, National Institute
of Food and Drug Safety Evaluation (NIFDS), Korea Food and Drug Administration
(KFDA), Chungbuk, Republic of Korea
6
Unable to attend: Farmacopea Argentina, Buenos Aires, Argentina; Farmacopéia Brasileria, Santa Maria RS,
Brazil.